Glycogen is a storage form of glucose molecules which are linked by α-1,4-glycosidic bonds. These α-1,4-linkages cause the chain structure to be helical rather than linear in 3-D structure. Glycogen is also unique among the biological macromolecules in that it is a branched polymer of glucose units-the branches are α-1,6-glycosidic bonds.
GLYCOGEN CATABOLISM: The key enzyme is of glycogen breakdown is phosphorylase (also called "glycogen phosphorylase"). It catalyzes the following reaction:
glycogen (n residues) + P i → glucose-1-phosphate + glycogen (n-1 residues) This reaction is advantageous over direct hydrolysis of glycogen to glucose molecules because glucose-1-phosphate (in fact, all phosphorylated monosaccharides) cannot diffuse from the cell, while free glucose can. In other words, the cell is greedy and will not let go of its sugars. The other advantage of this reaction is that phosphorylated glucose that can enter glycolysis (after conversion to glucose-6-phosphate by phosphoglucomutase) without wasting the ATP that would normally be utilized in converting glucose to glucose-6-phosphate (hexokinase step).
Remember also that the only organ of the body that has the enzyme glucose-6-phosphatase (last step of gluconeogenesis) is the liver. Therefore, the liver is the only organ that will release free glucose from glycogen breakdown. The fate of glucose-1-phosphate from glycogen breakdown in all other organs is the glycolytic pathway.
Branches are removed during glycogen catabolism by the action of the enzymes phosphorylase, a glycogen transferase enzyme, and a debranching enzyme known as α-1,6-glucosidase. The latter enzyme hydrolyzes the α-1,6-glycosidic linkage which forms the branch point of glycogen, in this case releasing a free glucose.
GLYCOGEN SYNTHESIS: The synthesis and breakdown of glycogen follow different pathways. Separate pathways result in metabolic flexibility in regulation of both energy and carbon flow. The major enzyme of glycogen synthesis is glycogen synthase, which catalyzed the following reaction: glycogen (n residues) + UDP-glucose → glycogen (n + 1) + UDP Note that the source of additional glucose molecules for glycogen synthase is UDP-glucose or "activated glucose." By "activated," we mean that the energy required to form the glycosidic bond between glucose units in glycogen has already been spent earlier in the formation of UDP-glucose, so that additional energy in the form of ATP or another nucleotide triphosphate is not needed by glycogen synthase itself. UDP-glucose is formed by the enzyme UDP-glucose pyrophosphorylase, which catalyzes the following reaction:
glucose-1-phosphate + UTP → UDP-glucose + PP i
Branches are added to glycogen by a special branching enzyme, which actually transfers a portion of an already-formed glycogen chain to form a branch, connected again by an α-1,6-glycosidic linkage. Branches are useful in glycogen because: (a) they increase the solubility of glycogen, and (b) they provide more free glycogen termini for the rapid release of glucose-1-phosphate by phosphorylase when it is needed.
HORMONAL CONTROL OF GLYCOGEN SYNTHESIS AND DEGRADATION:
Insulin stimulates cells, especially in the liver, to synthesize glycogen and stop glycogen breakdown. It also stimulates the uptake of glucose from the blood by most cells of the body. It is released by the pancreas in response to high blood glucose levels.
Epinephrine and glucagon increase the ability of cells in different organs to break down glycogen while stopping glycogen synthesis. Muscular activity causes the release of epinephrine by the adrenal medulla, which stimulates glycogen breakdown in the muscle (and to some extent in the liver and other organs). Glucagon is secreted in the pancreas when blood sugar is low, causing the liver to break down glycogen. The mechanisms of epinephrine and glucagon are well understood: they bind to specific receptor proteins on plasma membranes (outside surface), which activate the enzyme adenylate cyclase (inside the cell) to form cAMP from ATP. GLYCOGEN STORAGE DISEASES: A number of known metabolic disorders have been reported where a patient is lacking or deficient in one of the above enzymes involved in glycogen metabolism. The absence may be in the liver, the muscle, or both. Try to envision what symptoms these patients might have in the case of each enzyme noted above being deficient.
